ACRV
Acrivon Therapeutics, Inc. Common StockNASDAQHealthcare$1.52+4.11%ClosedMarket Cap: $48.0M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
11
Sales
8
Buy/Sell Ratio
1.38
Total Bought
$3.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Mar 03 | Peterson Katharine | officer: Chief Accounting Officer | Sell | 31,900 | $1.51 | 31,900 |
| Tue Mar 03 | Mirza Mansoor Raza | officer: Chief Medical Officer | Sell | 174,068 | $1.51 | 174,068 |
| Tue Mar 03 | Miller Mary | officer: Chief Legal Officer | Sell | 129,760 | $1.51 | 129,760 |
| Tue Mar 03 | Levy Adam D. | officer: Chief Financial Officer | Sell | 132,925 | $1.51 | 132,925 |
| Tue Mar 03 | Gamelin Erick | officer: Chief Development Officer | Sell | 94,946 | $1.51 | 94,946 |
| Tue Mar 03 | Devroe Eric | officer: Chief Operating Officer | Sell | 186,728 | $1.51 | 186,728 |
| Tue Mar 03 | Blume-Jensen Peter | director, officer: President and CEO | Sell | 417,210 | $1.51 | 417,210 |
| Tue Mar 03 | Blume-Jensen Peter | director, officer: President and CEO | Sell | 185,495 | $1.51 | 185,495 |
| Tue Feb 24 | Blume-Jensen Peter | director, officer: President and CEO | Sell | 14,265 | $1.53 | 2,080,204 |
| Wed Feb 18 | Peterson Katharine | officer: Chief Accounting Officer | Sell | 116 | $1.63 | 4,006 |